Evaluation of the Role of ALDH1 as Cancer Stem Cell Marker in Colorectal Carcinoma: An Immunohistochemical Study
Open Access
- 1 January 2017
- journal article
- Published by JCDR Research and Publications in Journal of Clinical and Diagnostic Research
- Vol. 11 (1) , EC17-EC23
Abstract
Journal of Clinical and Diagnostic Research aims to publish findings of doctors at grass root level and post graduate students, so that all unique medical experiences are recorded in literature.Keywords
This publication has 39 references indexed in Scilit:
- The expression of aldehyde dehydrogenase 1 (ALDH1) in ovarian carcinomas and its clinicopathological associations: a retrospective studyBMC Cancer, 2015
- Expression and prognostic value of tumor stem cell markers ALDH1 and CD133 in colorectal carcinomaOncology Letters, 2013
- Aldehyde dehydrogenase 1 expression in primary and metastatic renal cell carcinoma: an immunohistochemistry studyWorld Journal of Surgical Oncology, 2013
- Colorectal Adenoma Stem-like Cell Populations: Associations with Adenoma Characteristics and Metachronous Colorectal NeoplasiaCancer Prevention Research, 2013
- Aldehyde dehydrogenases in cellular responses to oxidative/electrophilicstressFree Radical Biology and Medicine, 2013
- Aldehyde Dehydrogenase Inhibitors: a Comprehensive Review of the Pharmacology, Mechanism of Action, Substrate Specificity, and Clinical ApplicationPharmacological Reviews, 2012
- Evidence for Epithelial-Mesenchymal Transition in Cancer Stem Cells of Head and Neck Squamous Cell CarcinomaPLOS ONE, 2011
- Aldehyde Dehydrogenase 1 Is a Marker for Normal and Malignant Human Colonic Stem Cells (SC) and Tracks SC Overpopulation during Colon TumorigenesisCancer Research, 2009
- Colorectal Cancer Stem Cells Are Enriched in Xenogeneic Tumors Following ChemotherapyPLOS ONE, 2008
- Stage II Colorectal Cancer: Lack of Prognostic ModelLibyan Journal of Medicine, 2007